ArticleJCO precision oncology2026

Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer.

Ansh Kapil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.